Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study (Q30318280)

17 June 2017

title

Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study (English)

1 reference

17 June 2017

0 references

4

0 references

Ursula Müller-Werdan

series ordinal

2

object named as

Ursula Müller-Werdan

1 reference

17 June 2017

Robert S Hoke

1

1 reference

17 June 2017

Christine Lautenschläger

series ordinal

3

1 reference

17 June 2017

Henning Ebelt

series ordinal

5

1 reference

17 June 2017

publication date

3 November 2011

1 reference

Clinical Research in Cardiology

17 June 2017

published in

1 reference

17 June 2017

volume

101

1 reference

17 June 2017

issue

2

1 reference

17 June 2017

page(s)

139-147

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Multiple organ failure. Pathophysiology and potential future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Resting heart rate in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Impaired regulation of cardiac function in sepsis, SIRS, and MODS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in LPS-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Heart rate reduction in cardiovascular disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Ivabradine for the treatment of stable angina pectoris in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Influence of heart rate on mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Relative tachycardia in patients with sepsis: an independent risk factor for mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0375-3

Septic cardiomyopathy - A not yet discovered cardiomyopathy?

21 January 2018

1 reference

12 December 2020

Relationship of changes in cardiac output to changes in heart rate in medical ICU patients

1 reference

12 December 2020

Measures of parasympathetic function and risk stratification in critical care

1 reference

12 December 2020

Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

1 reference

12 December 2020

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

1 reference

12 December 2020

Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1

1 reference

12 December 2020

Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors

1 reference

12 December 2020

Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications

1 reference

12 December 2020

Sir Isaac Newton, sepsis, SIRS, and CARS

1 reference

12 December 2020

Endotoxin impairs the human pacemaker current If.

1 reference

12 December 2020

Ultimate survival from septic shock

1 reference

12 December 2020

Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock

1 reference

12 December 2020

Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study

1 reference

12 December 2020

[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]

1 reference

12 December 2020

Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study

1 reference

12 December 2020

Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage

1 reference

12 December 2020

The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial

1 reference

12 December 2020

Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases

1 reference

12 December 2020

Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use

1 reference

12 December 2020

10.1007/S00392-011-0375-3

Identifiers

DOI

1 reference

17 June 2017

1 reference